Morbilliform Rash Secondary to Baclofen Ingestion
Ann Neurol 13:216, Lynde,C.W.,et al, 1983
Adult Inorganic Lead Intoxication:Presentation of 31 New Cases & a Review of Recent Advances in the Literature
Medicine 62:221-247, Cullen,M.R.,et al, 1983
Phytanic Acid Storage Disease:Hearing Maintained After 15 Years of Dietary Treatment
Neurol 33:237-240, Djupesland,G.,et al, 1983
Baclofen, Its Effect on Seizure Frequency
Arch Neurol 40:28-29, Terrence,C.F.,et al, 1983
Hepatic & Cerebral Pathology Findings in Children with Fatal Salicylate Intoxication
Lancet 1:326-329, Starko,K.M.,et al, 1983
Serum Folate Concentra. During Pregnancy in Women with Epilepsy:Relation to Antiepileptic Drug Concentrations
BMJ 287:577-579, Hiilesmaa,V.K.,et al, 1983
Safe Readministration of Valproate after an Episode of Hepatotoxicity
Ann Neurol 13:688, Ramsay,R.E., 1983
Valproic Acid & Fetal Abnormality
BMJ 286:190, Bailey,C.J.,et al, 1983
Valproic Acid Therapy for Complex Partial Seizures, Its Efficacy & Toxic Effects
Arch Neurol 40:135-137, Bruni,J.,et al, 1983
Plasma Concentrations of Sodium Valproate:Their Clinical Value
Ann Neurol 14:38-42, Turnbull,D.M.,et al, 1983
Valproic Acid & Intractable Seizures in Severely Brain-Damaged Patients
Neurol 33:99-101, Chayasirisobhon,S.,et al, 1983
Valproic Acid, Treatment of Myoclonus in Dyssynergia Cerebellaris Myoclonica
Arch Neurol 39:527-528, Sommerville,E.R.,et al, 1982
Sodium Valproate-induced Hyperammonemia Without Clinical Hepatic Dysfunction
Neurol 32:206-208, Zaret,B.S.,et al, 1982
Pure Red Cell Aplasia Associated with Sodium Valproate Therapy
JAMA 247:53-54, MacDougall,L.G.,et al, 1982
Current Status of Antifibrinolytic Therapy for Treatment of Patients with Aneurysmal Subarachnoid Hemorrhage
Jr. , Stroke 13:256-259982., Adams,H.P., 1982
Amelioration of Hemiballismus with Sodium Valproate
Ann Neurol 12:407, Chandra,V.,et al, 1982
Efficacy of a Combination of Sodium Valproate & Baclofen in Meige's Disease (idiopathic orofacial dystonia)
BMJ 285:853, Brennan,M.J.W.,et al, 1982
Aspirin as a Risk Factor in Reye's Syndrome
JAMA 247:3089-3094, Waldman,R.J.,et al, 1982
Reye's Syndrome & Medication Use
JAMA 248:687-691, Halpin,T.J.,et al, 1982
Treatment of Primary Reading Epilepsy With Valproic Acid
Arch Neurol 39:452-453, Vanderzant,C.,et al, 1982
Valproic Acid in the Treatment of Nonepileptic Myoclonus
Arch Neurol 39:448-449, Sotaniemi,K.,et al, 1982
Valproate & Clonazepam in the Treatment of Severe Progressive Myoclonus Epilepsy
Arch Neurol 39:236-238, Iivanainen,M.,et al, 1982
Asymptomatic Hyperammonemia in Patients Receiving Valproic Acid
Arch Neurol 39:591-592, Murphy,J.V.,et al, 1982
A Comparison of Phenytoin & Valproate in Previously Untreated Adult Epileptic Patients
JNNP 45:55-59, Turnbull,D.M.,et al, 1982
Serum Salicylate Concentrations In Reye's Disease
Lancet 1:191-193, Partin,J.S.,et al, 1982
Acute Intracranial Hypertension & Nalidixic Acid Therapy
Neurol 32:212-215, Gedroyc,W.,et al, 1982
Use of Valproic Acid in Treatment of Infantile Spasms
Arch Neurol 39:49-52, Bachman,D.S., 1982
Phenytoin-valproate Interaction:Importance of Saliva Monitoring in Epilepsy
BMJ 284:13-16, Knott,C.,et al, 1982
Valproic Acid Versus Ethosuximide in the Treatment of Absence Seizures
Neurol 32:157-163, Sato,S.,et al, 1982
Monitoring of Serum Amylase Levels During Valproic Acid Therapy
Ann Neurol 11:217-218, Bale,J.F.,et al, 1982
Valproic Acid & Secondary Hyperammonemia
Neurol 31:1173-1174, Rawat,S.,et al, 1981
Changes in the Basal Ganglia Following Cyanide Poisoning
J Comput Assist Tomogr 5:755-756, Finelli,P.F., 1981
Heredopathia Atactica Polyneuritiformis
Arch Neurol 38:605-606, Refsum,S., 1981
Valproic Acid in Sydenham's Chorea
BMJ 283:274-275, McLachlam,R.S., 1981
Spasticity
et al (Part 1 & 2) NEJM 304:28-33, 96-99., Young,R.R., 1981
Febrile Convulsions:Long-term Treatment
Editorial, BMJ 282:673-6741981., , 1981
Valproate-induced Stomatitis
Jr. , Neurol 31:329-331981., Russo,L.S., 1981
Asterixis Associated with Sodium Valproate
Neurol 31:194-195, Bodensteiner,J.B.,et al, 1981
Adrenoleukodystrophy:Increased Plasma Content of Saturated Very Long Chain Fatty Acids
Neurol 31:1241-1249, Moser,H.W.,et al, 1981
Cerebral Vasodilators (Second of Two Parts)
NEJM 305:1560-1564, Cook,P.,et al, 1981
Complications of Baclofen Withdrawal
Arch Neurol 38:588-589, Terrence,C.F.,et al, 1981
Sweat Gland Duct Cells in Lafora Disease:Diagnosis by Skin Biopsy
Neurol 31:1564-1568, Carpenter,S.,et al, 1981
Improvement of Stiff-man Syndrome with Sodium Valproate
Neurol 31:1162-1163, Spehlmann,R.,et al, 1981
Treatment of Intractable Hiccups with Valproic Acid
Neurol 31:1458-1460, Jacobson,P.L.,et al, 1981
Community-Acquired Purulent Meningitis of Unknown Etiology
Arch Neurol 38:749-753, Geiseler,P.J.,et al, 1981
Management of Cerebral Aneurysm
Stroke 12:273-283, Drake,C.G.,et al, 1981
Hemiballismus Treated with Sodium Valproate
BMJ 283:17-18, Lenton,R.J.,et al, 1981
Baclofen in the Treatment of Stiff-Man Syndrome
Ann Neurol 9:511-512, Miller,F.,et al, 1981
Concentration Of Gammahydroxybutyric Acid In Ventricular & Lumbar Cerebrospinal Fluid
III, et al, NEJM 304:93-95981., Snead,O.C., 1981
Progressive Infantile Poliodystrophy, Assoc. With Disturbed Pyruvate Oxidation in Muscle & Liver
Arch Neurol 38:767-772, Prick,M.J.J.,et al, 1981